Valuation : G MEDPAR

Market Cap 7L 6L 6L 5L 10.02L 6.91Cr 10.05L 68.8L 26.9L 3.48Cr 27.14L 26.56L 12Cr P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 25.2L 21.63L 20.25L 18.54L 34.93L 24Cr 35.03L 2.4Cr 93.75L 12Cr 94.61L 92.57L 40Cr EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0.03
3 years 0
Extreme 1.0E-6
0.1
5 years 0
Extreme 1.0E-6
235.9
10 years 0
Extreme 1.0E-6
235.9
Manager TitleAgeSince
Chief Executive Officer 75 03/10/2014
Director of Finance/CFO 46 31/07/2022
Chief Tech/Sci/R&D Officer 56 01/12/2017
Director TitleAgeSince
Director/Board Member 75 03/10/2014
Chairman 72 21/08/2014
Director/Board Member 76 24/02/2017
Date Insider Type Main position Quantity % Market Cap.
31/03/23
AWM Investment Co., Inc.
SellCompany 7,37,500 37.5554%
31/03/23
AWM Investment Co., Inc.
OtherCompany 14,37,500 73.2011%

Financials

2021 2022
Net sales 50.58L 43.42L 40.65L 37.22L 70.12L 48Cr 70.32L 4.81Cr 1.88Cr 24Cr 1.9Cr 1.86Cr 81Cr 44.2L 37.94L 35.52L 32.53L 61.27L 42Cr 61.45L 4.21Cr 1.64Cr 21Cr 1.66Cr 1.62Cr 70Cr
Net income -1.48Cr -1.27Cr -1.19Cr -1.09Cr -2.05Cr -140.95Cr -2.05Cr -14Cr -5.49Cr -71Cr -5.54Cr -5.42Cr -235.11Cr -1.35Cr -1.16Cr -1.09Cr -99.5L -1.87Cr -129.14Cr -1.88Cr -13Cr -5.03Cr -65Cr -5.08Cr -4.97Cr -215.4Cr
Net Debt 24.08L 20.67L 19.35L 17.72L 33.38L 23Cr 33.48L 2.29Cr 89.58L 12Cr 90.41L 88.46L 38Cr 17.97L 15.43L 14.44L 13.22L 24.91L 17Cr 24.98L 1.71Cr 66.85L 8.65Cr 67.47L 66.01L 29Cr
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
-
Sector
-
Date Price Change Volume
24/26/24 $0.000100 0.00% 1,322
  1. Stock Market
  2. Stocks
  3. GMVDF Stock